SEC Tracker
Get the app

Outlook Therapeutics OTLK

Outlook Therapeutics Announces $10 Million Bought Deal Offering of Common Stock

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 99.1
Press release
  • Signs a material agreement (1.01)
  • Sells unregistered shares (3.02)
  • Discloses other events (8.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Outlook Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. OnKure Therapeutics OKUR public float $28M, Jun 30, 2025
  2. Palatin Technologies PTN public float $26M, Dec 31, 2025
  3. Scynexis SCYX public float $26M, Jun 30, 2025
  4. Champions Oncology CSBR public float $29M, Oct 31, 2025
  5. Rockwell Medical RMTI public float $29M, Jun 30, 2025